GPT and chronic hepatitis: Twenty-one patients were in HBeAg-negative chronic hepatitis phase and 7 patients in HBeAg-positive chronic hepatitis phase; 26 patients (92.9%) presented abnormal elevated ALT measurements before starting treatment.